The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial (SOLID-TIMI 52)
This study is ongoing, but not recruiting participants.
Sponsor:
GlaxoSmithKline
Collaborator:
The TIMI Study Group
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01000727
First received: October 22, 2009
Last updated: October 25, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study will test whether darapladib can safely lower the chances of having a cardiovascular event (such as a heart attack or stroke) when treatment is started within 30 days after an acute coronary syndrome (also called ACS).
| Condition | Intervention | Phase |
|---|---|---|
|
Atherosclerosis Acute Coronary Syndrome Cardiovascular Disease Coronary Heart Disease |
Drug: Darapladib 160 mg Drug: Placebo |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE). |
Resource links provided by NLM:
Further study details as provided by GlaxoSmithKline:
Primary Outcome Measures:
- Time to the first occurrence of any component of the composite of Major Adverse Cardiovascular Events [MACE: CV death (death due to a cardiovascular cause), non-fatal myocardial infarction, non-fatal stroke]. [ Time Frame: Through the end of the study. ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- The composite measure of major coronary events that include the first occurrence of coronary heart disease death, non-fatal myocardial infarction or urgent coronary revascularization for myocardial ischemia. [ Time Frame: Through the end of the study. ] [ Designated as safety issue: No ]
- The composite measure of total coronary events that include the first occurrence of coronary heart disease death, non-fatal MI, hospitalization for UA, or any coronary revasc procedure (excluding PCI planned prior to but performed after randomization). [ Time Frame: Through the end of the study. ] [ Designated as safety issue: No ]
- The individual components of MACE [cardiovascular death, myocardial infarction (fatal and non-fatal), stroke (fatal and non-fatal)]. [ Time Frame: Through the end of the study. ] [ Designated as safety issue: No ]
- The first occurrence of any component of the composite of all-cause mortality, non-fatal myocardial infarction, or non-fatal stroke. [ Time Frame: Through the end of the study. ] [ Designated as safety issue: No ]
- All cause mortality. [ Time Frame: Through the end of the study. ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 13000 |
| Study Start Date: | December 2009 |
| Estimated Study Completion Date: | April 2014 |
| Estimated Primary Completion Date: | April 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Darapladib 160 mg
Single daily oral tablet
|
Drug: Darapladib 160 mg
Lp-PLA2 inhibitor administered in addition to standard therapy.
Other Name: SB-480848
|
|
Placebo Comparator: Placebo
Single daily oral tablet
|
Drug: Placebo
Placebo administered in addition to standard therapy.
|
Detailed Description:
Subjects who qualify for the study will be randomized 1:1 to either darapladib or placebo administered in addition to standard therapy. Following the baseline visit, subjects will be expected to return for clinic visits at 1 month, 3 months, 6 months and every 6 months until the end of the study.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Signed written informed consent.
- Men or women at least 18 years old (in Taiwan, at least 20 years old). Women must be post-menopausal or using a highly effective method for avoidance of pregnancy.
- Hospitalization for acute coronary syndrome (ACS) within 30 days prior to study entry.
- Clinically stable for 24 hours prior to study entry.
- A planned percutaneous coronary intervention (PCI) should be performed prior to study entry, whenever possible.
- At least one of the following:
- At least 60 years old.
- Myocardial infarction prior to the qualifying ACS event.
- Diabetes mellitus requiring treatment with medication.
- Diagnosed mild or moderate reduction in kidney function.
- Cerebrovascular disease (carotid artery disease or ischemic stroke more than 3 months prior to study entry) OR peripheral artery disease.
Exclusion Criteria:
- ACS symptoms or lab results not believed to be caused by a narrowing or blocked coronary artery.
- No major coronary artery with a blockage of more than 50% (unless all stenoses are successfully treated by PCI).
- Planned coronary artery bypass graft (CABG) surgery, or CABG surgery performed after the qualifying ACS event and prior to study entry.
- Certain types of liver disease.
- Severe reduction in kidney function OR removal of a kidney OR kidney transplant.
- Severe heart failure.
- Blood pressure higher than normal despite lifestyle changes and treatment with medications.
- Any life-threatening disease with a life expectancy of less than 2 years (other than heart disease) that may prevent the subject from completing the study.
- Severe asthma that is poorly controlled with medication.
- Pregnancy (Note: A pregnancy test will be performed on all non-sterile women prior to study entry).
- Previous severe allergic reaction to food, medications, drink, insect stings, etc.
- Drug or alcohol abuse within the past 6 months. Mental/psychological impairment that may prevent the subject from complying with study procedures or understanding the goal and potential risks of participating in the study.
- Certain medications that may interfere with the study medication (these will be identified by the study doctor).
- If both birth parents are at least 50% Japanese, Chinese, or Korean ancestry, must have a blood sample collected for Lp-PLA2 activity. Those with Lp-PLA2 activity less than or equal to 20.0 nmol/min/mL are excluded.
- Previously took darapladib (SB-480848).
- Participation in a study of an investigational medication within the past 30 days.
- Current participation in a study of an investigational device.
- Any other reason the investigator deems the subject should not participate in the study.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01000727
Hide Study Locations
Hide Study LocationsLocations
| United States, Alabama | |
| GSK Investigational Site | |
| Birmingham, Alabama, United States, 35213 | |
| GSK Investigational Site | |
| Birmingham, Alabama, United States, 35209 | |
| GSK Investigational Site | |
| Birmingham, Alabama, United States, 35294 | |
| GSK Investigational Site | |
| Huntsville, Alabama, United States, 35801 | |
| GSK Investigational Site | |
| Mobile, Alabama, United States, 36608 | |
| GSK Investigational Site | |
| Mobile, Alabama, United States, 36604 | |
| United States, Alaska | |
| GSK Investigational Site | |
| Anchorage, Alaska, United States, 99508 | |
| United States, Arizona | |
| GSK Investigational Site | |
| Cottonwood, Arizona, United States, 86326 | |
| GSK Investigational Site | |
| Glendale, Arizona, United States, 85306 | |
| GSK Investigational Site | |
| Tucson, Arizona, United States, 85710 | |
| GSK Investigational Site | |
| Tucson, Arizona, United States, 85723 | |
| GSK Investigational Site | |
| Tucson, Arizona, United States, 85724 | |
| United States, Arkansas | |
| GSK Investigational Site | |
| Fort Smith, Arkansas, United States, 72903 | |
| GSK Investigational Site | |
| Jonesboro, Arkansas, United States, 72401 | |
| GSK Investigational Site | |
| Little Rock, Arkansas, United States, 72205 | |
| United States, California | |
| GSK Investigational Site | |
| Bakersfield, California, United States, 93308 | |
| GSK Investigational Site | |
| Bakersfield, California, United States, 93309 | |
| GSK Investigational Site | |
| Beverly Hills, California, United States, 90211 | |
| GSK Investigational Site | |
| Fresno, California, United States, 93721 | |
| GSK Investigational Site | |
| La Mesa, California, United States, 91942 | |
| GSK Investigational Site | |
| Lomita, California, United States, 90717 | |
| GSK Investigational Site | |
| Los Alamitos, California, United States, 90720 | |
| GSK Investigational Site | |
| Los Angeles, California, United States, 90049 | |
| GSK Investigational Site | |
| Los Angeles, California, United States, 90073 | |
| GSK Investigational Site | |
| Los Angeles, California, United States, 90015 | |
| GSK Investigational Site | |
| Mission Hills, California, United States, 91345 | |
| GSK Investigational Site | |
| Roseville, California, United States, 95661 | |
| GSK Investigational Site | |
| Sacramento, California, United States, 95819 | |
| GSK Investigational Site | |
| San Diego, California, United States, 92161 | |
| GSK Investigational Site | |
| Santa Ana, California, United States, 92704 | |
| GSK Investigational Site | |
| Santa Ana, California, United States, 92705 | |
| GSK Investigational Site | |
| Torrance, California, United States, 90509 | |
| GSK Investigational Site | |
| Tracy, California, United States, 95376 | |
| GSK Investigational Site | |
| Ventura, California, United States, 93003 | |
| GSK Investigational Site | |
| Westlake Village, California, United States, 91361 | |
| United States, Colorado | |
| GSK Investigational Site | |
| Colorado Springs, Colorado, United States, 80920 | |
| GSK Investigational Site | |
| Golden, Colorado, United States, 80401 | |
| GSK Investigational Site | |
| Greeley, Colorado, United States, 80631 | |
| GSK Investigational Site | |
| Littleton, Colorado, United States, 80120 | |
| GSK Investigational Site | |
| Wheat Ridge, Colorado, United States, 80033 | |
| United States, Connecticut | |
| GSK Investigational Site | |
| Bridgeport, Connecticut, United States, 06606 | |
| GSK Investigational Site | |
| Bridgeport, Connecticut, United States, 06610 | |
| GSK Investigational Site | |
| Guilford, Connecticut, United States, 06437 | |
| GSK Investigational Site | |
| Hartford, Connecticut, United States, 06102 | |
| United States, Florida | |
| GSK Investigational Site | |
| Atlantis, Florida, United States, 33462 | |
| GSK Investigational Site | |
| Aventura, Florida, United States, 33180 | |
| GSK Investigational Site | |
| Brandon, Florida, United States, 33511 | |
| GSK Investigational Site | |
| Clearwater, Florida, United States, 33756 | |
| GSK Investigational Site | |
| Daytona Beach, Florida, United States, 32117 | |
| GSK Investigational Site | |
| Daytona Beach, Florida, United States, 32114 | |
| GSK Investigational Site | |
| Fleming Island, Florida, United States, 32003 | |
| GSK Investigational Site | |
| Fort Lauderdale, Florida, United States, 33316 | |
| GSK Investigational Site | |
| Gainesville, Florida, United States, 32610 | |
| GSK Investigational Site | |
| Gulf Breeze, Florida, United States, 32561 | |
| GSK Investigational Site | |
| Hollywood, Florida, United States, 33021 | |
| GSK Investigational Site | |
| Inverness, Florida, United States, 34452 | |
| GSK Investigational Site | |
| Jacksonville, Florida, United States, 32207 | |
| GSK Investigational Site | |
| Jacksonville, Florida, United States, 32209 | |
| GSK Investigational Site | |
| Jacksonville, Florida, United States, 32216 | |
| GSK Investigational Site | |
| Jacksonville Beach, Florida, United States, 32250 | |
| GSK Investigational Site | |
| Jupiter, Florida, United States, 33458 | |
| GSK Investigational Site | |
| Kissimmee, Florida, United States, 34741 | |
| GSK Investigational Site | |
| Miramar, Florida, United States, 33025 | |
| GSK Investigational Site | |
| Ocala, Florida, United States, 34471 | |
| GSK Investigational Site | |
| Palm Beach Gardens, Florida, United States, 33410 | |
| GSK Investigational Site | |
| Pensacola, Florida, United States, 32501 | |
| GSK Investigational Site | |
| Pensacola, Florida, United States, 32504 | |
| GSK Investigational Site | |
| Plantation, Florida, United States, 33317 | |
| GSK Investigational Site | |
| Port Charlotte, Florida, United States, 33952 | |
| GSK Investigational Site | |
| Safety Harbor, Florida, United States, 34695 | |
| GSK Investigational Site | |
| Sarasota, Florida, United States, 34232 | |
| GSK Investigational Site | |
| St. Petersburg, Florida, United States, 33713 | |
| GSK Investigational Site | |
| Tallahassee, Florida, United States, 32308 | |
| GSK Investigational Site | |
| Trinity, Florida, United States, 34655 | |
| GSK Investigational Site | |
| Vero Beach, Florida, United States, 32960 | |
| GSK Investigational Site | |
| Wellington, Florida, United States, 33449 | |
| United States, Georgia | |
| GSK Investigational Site | |
| Atlanta, Georgia, United States, 30342 | |
| GSK Investigational Site | |
| Augusta, Georgia, United States, 30901 | |
| GSK Investigational Site | |
| Cumming, Georgia, United States, 30041 | |
| United States, Idaho | |
| GSK Investigational Site | |
| Boise, Idaho, United States, 83712 | |
| United States, Illinois | |
| GSK Investigational Site | |
| Aurora, Illinois, United States, 60504 | |
| GSK Investigational Site | |
| Bannockburn, Illinois, United States, 60015 | |
| GSK Investigational Site | |
| Chicago, Illinois, United States, 60612 | |
| GSK Investigational Site | |
| Lombard, Illinois, United States, 60148 | |
| GSK Investigational Site | |
| Melrose Park, Illinois, United States, 60160 | |
| GSK Investigational Site | |
| Mokena, Illinois, United States, 60448 | |
| GSK Investigational Site | |
| North Chicago, Illinois, United States, 60064 | |
| GSK Investigational Site | |
| Oakbrook Terrace, Illinois, United States, 60181 | |
| GSK Investigational Site | |
| Park Ridge, Illinois, United States, 60068 | |
| GSK Investigational Site | |
| Peoria, Illinois, United States, 61614 | |
| GSK Investigational Site | |
| Rock Island, Illinois, United States, 61201 | |
| United States, Indiana | |
| GSK Investigational Site | |
| Fort Wayne, Indiana, United States, 46804 | |
| GSK Investigational Site | |
| Hammond, Indiana, United States, 46320 | |
| GSK Investigational Site | |
| Indianapolis, Indiana, United States, 46202 | |
| GSK Investigational Site | |
| Indianapolis, Indiana, United States, 46290 | |
| GSK Investigational Site | |
| Indianapolis, Indiana, United States, 46237 | |
| GSK Investigational Site | |
| Muncie, Indiana, United States, 47303 | |
| GSK Investigational Site | |
| Munster, Indiana, United States, 46321 | |
| GSK Investigational Site | |
| South Bend, Indiana, United States, 46601-1066 | |
| GSK Investigational Site | |
| Valparaiso, Indiana, United States, 46383 | |
| United States, Iowa | |
| GSK Investigational Site | |
| Iowa City, Iowa, United States, 52242 | |
| GSK Investigational Site | |
| West Des Moines, Iowa, United States, 50266 | |
| United States, Kentucky | |
| GSK Investigational Site | |
| Crestview Hill, Kentucky, United States, 41017 | |
| GSK Investigational Site | |
| Lexington, Kentucky, United States, 40536-0294 | |
| GSK Investigational Site | |
| Louisville, Kentucky, United States, 40205 | |
| GSK Investigational Site | |
| Louisville, Kentucky, United States, 40207 | |
| United States, Louisiana | |
| GSK Investigational Site | |
| Alexandria, Louisiana, United States, 71301 | |
| GSK Investigational Site | |
| Lafayette, Louisiana, United States, 70506 | |
| GSK Investigational Site | |
| Lake Charles, Louisiana, United States, 70601 | |
| GSK Investigational Site | |
| Shreveport, Louisiana, United States, 71105 | |
| United States, Maine | |
| GSK Investigational Site | |
| Auburn, Maine, United States, 04210 | |
| GSK Investigational Site | |
| Bangor, Maine, United States, 04401 | |
| GSK Investigational Site | |
| Scarborough, Maine, United States, 04074 | |
| United States, Maryland | |
| GSK Investigational Site | |
| Baltimore, Maryland, United States, 21201 | |
| GSK Investigational Site | |
| Baltimore, Maryland, United States, 21236 | |
| GSK Investigational Site | |
| Baltimore, Maryland, United States, 21208 | |
| GSK Investigational Site | |
| Baltimore, Maryland, United States, 21218 | |
| GSK Investigational Site | |
| Baltimore, Maryland, United States, 21229 | |
| GSK Investigational Site | |
| Bel Air, Maryland, United States, 21014 | |
| GSK Investigational Site | |
| Columbia, Maryland, United States, 21044 | |
| GSK Investigational Site | |
| Salisbury, Maryland, United States, 21801 | |
| GSK Investigational Site | |
| Towson, Maryland, United States, 21204 | |
| United States, Massachusetts | |
| GSK Investigational Site | |
| Ayer, Massachusetts, United States, 01432 | |
| GSK Investigational Site | |
| Boston, Massachusetts, United States, 02111 | |
| GSK Investigational Site | |
| Boston, Massachusetts, United States, 02115 | |
| GSK Investigational Site | |
| Fall River, Massachusetts, United States, 02720 | |
| GSK Investigational Site | |
| Springfield, Massachusetts, United States, 01199 | |
| GSK Investigational Site | |
| Worcester, Massachusetts, United States, 01655 | |
| United States, Michigan | |
| GSK Investigational Site | |
| Ann Arbor, Michigan, United States, 48109 | |
| GSK Investigational Site | |
| Dearborn, Michigan, United States, 48124 | |
| GSK Investigational Site | |
| Detroit, Michigan, United States, 48201 | |
| GSK Investigational Site | |
| Flint, Michigan, United States, 48532 | |
| GSK Investigational Site | |
| Kalamazoo, Michigan, United States, 49048 | |
| GSK Investigational Site | |
| Marquette, Michigan, United States, 49855 | |
| GSK Investigational Site | |
| Pontiac, Michigan, United States, 48341-2985 | |
| GSK Investigational Site | |
| Troy, Michigan, United States, 48085 | |
| GSK Investigational Site | |
| Ypsilanti, Michigan, United States, 48197 | |
| United States, Minnesota | |
| GSK Investigational Site | |
| Duluth, Minnesota, United States, 55805 | |
| GSK Investigational Site | |
| Minneapolis, Minnesota, United States, 55426 | |
| GSK Investigational Site | |
| Robbinsdale, Minnesota, United States, 55422 | |
| GSK Investigational Site | |
| Saint Paul, Minnesota, United States, 55101 | |
| GSK Investigational Site | |
| St Cloud, Minnesota, United States, 56303 | |
| United States, Mississippi | |
| GSK Investigational Site | |
| Tupelo, Mississippi, United States, 38801 | |
| United States, Missouri | |
| GSK Investigational Site | |
| Columbia, Missouri, United States, 65212 | |
| GSK Investigational Site | |
| Joplin, Missouri, United States, 64804 | |
| GSK Investigational Site | |
| kansas City, Missouri, United States, 64114 | |
| GSK Investigational Site | |
| Springfield, Missouri, United States, 65804 | |
| GSK Investigational Site | |
| St Louis, Missouri, United States, 63110 | |
| GSK Investigational Site | |
| St. Louis, Missouri, United States, 63128 | |
| United States, Montana | |
| GSK Investigational Site | |
| Columbia, Montana, United States, 65201 | |
| GSK Investigational Site | |
| Great Falls, Montana, United States, 59405 | |
| GSK Investigational Site | |
| Kalispell, Montana, United States, 59901 | |
| United States, Nebraska | |
| GSK Investigational Site | |
| Grand Island, Nebraska, United States, 68803 | |
| GSK Investigational Site | |
| Lincoln, Nebraska, United States, 68526 | |
| GSK Investigational Site | |
| Omaha, Nebraska, United States, 68131 | |
| GSK Investigational Site | |
| Papillion, Nebraska, United States, 68046 | |
| United States, Nevada | |
| GSK Investigational Site | |
| Las Vegas, Nevada, United States, 89103 | |
| United States, New Jersey | |
| GSK Investigational Site | |
| Browns Mills, New Jersey, United States, 08015 | |
| GSK Investigational Site | |
| Cherry Hill, New Jersey, United States, 08034 | |
| GSK Investigational Site | |
| Elizabeth, New Jersey, United States, 07202 | |
| GSK Investigational Site | |
| Elmer, New Jersey, United States, 8318 | |
| GSK Investigational Site | |
| Haddon Heights, New Jersey, United States, 08035 | |
| GSK Investigational Site | |
| Linden, New Jersey, United States, 07036 | |
| GSK Investigational Site | |
| Paterson, New Jersey, United States, 07503 | |
| GSK Investigational Site | |
| Pomona, New Jersey, United States, 8240 | |
| GSK Investigational Site | |
| Sewell, New Jersey, United States, 08080 | |
| GSK Investigational Site | |
| Somerset, New Jersey, United States, 08873 | |
| GSK Investigational Site | |
| Summit, New Jersey, United States, 07902 | |
| GSK Investigational Site | |
| West Orange, New Jersey, United States, 07052 | |
| United States, New Mexico | |
| GSK Investigational Site | |
| Albuquerque, New Mexico, United States, 87131-0001 | |
| United States, New York | |
| GSK Investigational Site | |
| Albany, New York, United States, 12211 | |
| GSK Investigational Site | |
| Bronx, New York, United States, 10467 | |
| GSK Investigational Site | |
| Brooklyn, New York, United States, 11219 | |
| GSK Investigational Site | |
| Buffalo, New York, United States, 14215 | |
| GSK Investigational Site | |
| Cortlandt Manor, New York, United States, 10567 | |
| GSK Investigational Site | |
| New York, New York, United States, 10016 | |
| GSK Investigational Site | |
| New York, New York, United States, 10001 | |
| GSK Investigational Site | |
| New York, New York, United States, 10021 | |
| GSK Investigational Site | |
| Roslyn, New York, United States, 11576 | |
| GSK Investigational Site | |
| Stony Brook, New York, United States, 11794 | |
| GSK Investigational Site | |
| Syracuse, New York, United States, 13202 | |
| GSK Investigational Site | |
| Troy, New York, United States, 12180 | |
| GSK Investigational Site | |
| Williamsville, New York, United States, 14221 | |
| United States, North Carolina | |
| GSK Investigational Site | |
| Asheville, North Carolina, United States, 28803 | |
| GSK Investigational Site | |
| Burlington, North Carolina, United States, 27215 | |
| GSK Investigational Site | |
| Charlotte, North Carolina, United States, 28204 | |
| GSK Investigational Site | |
| Concord, North Carolina, United States, 28025 | |
| GSK Investigational Site | |
| Gastonia, North Carolina, United States, 28054 | |
| GSK Investigational Site | |
| Greensboro, North Carolina, United States, 27401 | |
| GSK Investigational Site | |
| Huntersville, North Carolina, United States, 28078 | |
| GSK Investigational Site | |
| Matthews, North Carolina, United States, 28105 | |
| GSK Investigational Site | |
| Monroe, North Carolina, United States, 28112 | |
| GSK Investigational Site | |
| Pinehurst, North Carolina, United States, 28374 | |
| GSK Investigational Site | |
| Raleigh, North Carolina, United States, 27610 | |
| GSK Investigational Site | |
| Rocky Mount, North Carolina, United States, 27804 | |
| GSK Investigational Site | |
| Salisbury, North Carolina, United States, 28144 | |
| GSK Investigational Site | |
| Sanford, North Carolina, United States, 27330 | |
| GSK Investigational Site | |
| Winston-Salem, North Carolina, United States, 27157 | |
| United States, North Dakota | |
| GSK Investigational Site | |
| Grand Forks, North Dakota, United States, 58201 | |
| United States, Ohio | |
| GSK Investigational Site | |
| Canton, Ohio, United States, 44718 | |
| GSK Investigational Site | |
| Cincinnati, Ohio, United States, 45267 | |
| GSK Investigational Site | |
| Cincinnati, Ohio, United States, 45219 | |
| GSK Investigational Site | |
| Cleveland, Ohio, United States, 44106 | |
| GSK Investigational Site | |
| Dayton, Ohio, United States, 45414 | |
| GSK Investigational Site | |
| Elyria, Ohio, United States, 44035 | |
| GSK Investigational Site | |
| Fairfield, Ohio, United States, 45014 | |
| GSK Investigational Site | |
| Fairview Park, Ohio, United States, 44126 | |
| GSK Investigational Site | |
| Lorain, Ohio, United States, 44053 | |
| GSK Investigational Site | |
| Mansfield, Ohio, United States, 44906 | |
| GSK Investigational Site | |
| Middleburg Heights, Ohio, United States, 44130 | |
| GSK Investigational Site | |
| Sandusky, Ohio, United States, 44870 | |
| GSK Investigational Site | |
| Toledo, Ohio, United States, 43614 | |
| GSK Investigational Site | |
| Toledo, Ohio, United States, 43606 | |
| GSK Investigational Site | |
| Youngstown, Ohio, United States, 44501-1790 | |
| GSK Investigational Site | |
| Zaneville, Ohio, United States, 43701 | |
| United States, Oklahoma | |
| GSK Investigational Site | |
| Midwest City, Oklahoma, United States, 73110 | |
| GSK Investigational Site | |
| Oklahoma, Oklahoma, United States, 73104 | |
| GSK Investigational Site | |
| Oklahoma City, Oklahoma, United States, 73112 | |
| United States, Oregon | |
| GSK Investigational Site | |
| Portland, Oregon, United States, 97220 | |
| GSK Investigational Site | |
| Portland, Oregon, United States, 97239 | |
| United States, Pennsylvania | |
| GSK Investigational Site | |
| Allentown, Pennsylvania, United States, 18103 | |
| GSK Investigational Site | |
| Beaver, Pennsylvania, United States, 15009 | |
| GSK Investigational Site | |
| Bethlehem, Pennsylvania, United States, 18015 | |
| GSK Investigational Site | |
| Camp Hill, Pennsylvania, United States, 17011 | |
| GSK Investigational Site | |
| Chambersburg, Pennsylvania, United States, 17201 | |
| GSK Investigational Site | |
| Doylestown, Pennsylvania, United States, 18901 | |
| GSK Investigational Site | |
| Erie, Pennsylvania, United States, 16502 | |
| GSK Investigational Site | |
| Hershey, Pennsylvania, United States, 17033 | |
| GSK Investigational Site | |
| Jenkintown, Pennsylvania, United States, 19046 | |
| GSK Investigational Site | |
| Jersey Shore, Pennsylvania, United States, 17740 | |
| GSK Investigational Site | |
| Lancaster, Pennsylvania, United States, 17604 | |
| GSK Investigational Site | |
| Landsdale, Pennsylvania, United States, 19446 | |
| GSK Investigational Site | |
| Leetsdale, Pennsylvania, United States, 15056 | |
| GSK Investigational Site | |
| Philadelphia, Pennsylvania, United States, 19141 | |
| GSK Investigational Site | |
| Pittsburgh, Pennsylvania, United States, 15240 | |
| GSK Investigational Site | |
| Pittsburgh, Pennsylvania, United States, 15212 | |
| GSK Investigational Site | |
| Sayre, Pennsylvania, United States, 18840 | |
| GSK Investigational Site | |
| Scranton, Pennsylvania, United States, 18501 | |
| GSK Investigational Site | |
| Sellersville, Pennsylvania, United States, 18960 | |
| GSK Investigational Site | |
| West Chester, Pennsylvania, United States, 19380 | |
| GSK Investigational Site | |
| York, Pennsylvania, United States, 17405 | |
| United States, South Carolina | |
| GSK Investigational Site | |
| Charleston, South Carolina, United States, 29401 | |
| GSK Investigational Site | |
| Charleston, South Carolina, United States, 29425 | |
| GSK Investigational Site | |
| Columbia, South Carolina, United States, 29204 | |
| GSK Investigational Site | |
| Greenville, South Carolina, United States, 29607 | |
| United States, South Dakota | |
| GSK Investigational Site | |
| Rapid City, South Dakota, United States, 57701 | |
| United States, Tennessee | |
| GSK Investigational Site | |
| Chattanooga, Tennessee, United States, 37404 | |
| GSK Investigational Site | |
| Columbia, Tennessee, United States, 38401 | |
| GSK Investigational Site | |
| Jackson, Tennessee, United States, 38301 | |
| GSK Investigational Site | |
| Jackson, Tennessee, United States, 38305 | |
| GSK Investigational Site | |
| Johnson City, Tennessee, United States, 37604 | |
| GSK Investigational Site | |
| Nashville, Tennessee, United States, 37205 | |
| GSK Investigational Site | |
| Oak Ridge, Tennessee, United States, 37830 | |
| United States, Texas | |
| GSK Investigational Site | |
| Amarillo, Texas, United States, 79106 | |
| GSK Investigational Site | |
| Austin, Texas, United States, 78705 | |
| GSK Investigational Site | |
| Corpus Christi/Texas, Texas, United States, 78404 | |
| GSK Investigational Site | |
| Dallas, Texas, United States, 75390-8887 | |
| GSK Investigational Site | |
| Dallas, Texas, United States, 75226 | |
| GSK Investigational Site | |
| Fort Worth, Texas, United States, 76104 | |
| GSK Investigational Site | |
| Galveston, Texas, United States, 77555-0553 | |
| GSK Investigational Site | |
| Houston, Texas, United States, 77124 | |
| GSK Investigational Site | |
| Houston, Texas, United States, 77090 | |
| GSK Investigational Site | |
| Houston, Texas, United States, 77030 | |
| GSK Investigational Site | |
| Houston, Texas, United States, 77008 | |
| GSK Investigational Site | |
| Katy, Texas, United States, 77493 | |
| GSK Investigational Site | |
| Killeen, Texas, United States, 76549 | |
| GSK Investigational Site | |
| Kingwood, Texas, United States, 77339 | |
| GSK Investigational Site | |
| Round Rock, Texas, United States, 78681 | |
| GSK Investigational Site | |
| San Antonio, Texas, United States, 78229 | |
| GSK Investigational Site | |
| San Marcos, Texas, United States, 78666 | |
| GSK Investigational Site | |
| Sugar Land, Texas, United States, 77479 | |
| GSK Investigational Site | |
| Tyler, Texas, United States, 75708 | |
| GSK Investigational Site | |
| Victoria, Texas, United States, 77901 | |
| United States, Virginia | |
| GSK Investigational Site | |
| Lynchburg, Virginia, United States, 24501 | |
| GSK Investigational Site | |
| Midlothian, Virginia, United States, 23114 | |
| GSK Investigational Site | |
| Richmond, Virginia, United States, 23249 | |
| GSK Investigational Site | |
| Richmond, Virginia, United States, 23294 | |
| GSK Investigational Site | |
| Richmond, Virginia, United States, 23298 | |
| GSK Investigational Site | |
| Winchester, Virginia, United States, 22601 | |
| United States, Washington | |
| GSK Investigational Site | |
| Bellevue, Washington, United States, 98004 | |
| GSK Investigational Site | |
| Bellingham, Washington, United States, 98225 | |
| GSK Investigational Site | |
| Burien, Washington, United States, 98166 | |
| GSK Investigational Site | |
| Everett, Washington, United States, 98201 | |
| GSK Investigational Site | |
| Kirkland, Washington, United States, 98034 | |
| GSK Investigational Site | |
| Spokane, Washington, United States, 99204-2334 | |
| GSK Investigational Site | |
| Spokane, Washington, United States, 99204 | |
| GSK Investigational Site | |
| Tacoma, Washington, United States, 98405 | |
| GSK Investigational Site | |
| Walla Walla, Washington, United States, 99362 | |
| United States, Wisconsin | |
| GSK Investigational Site | |
| Beloit, Wisconsin, United States, 53511 | |
| GSK Investigational Site | |
| Green Bay, Wisconsin, United States, 54301 | |
| GSK Investigational Site | |
| Madison, Wisconsin, United States, 53713 | |
| GSK Investigational Site | |
| Wausau, Wisconsin, United States, 54401 | |
| Argentina | |
| GSK Investigational Site | |
| Capital Federal, Buenos Aires, Argentina, C1180AAX | |
| GSK Investigational Site | |
| Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina, C1179AAB | |
| GSK Investigational Site | |
| Mar del Plata, Buenos Aires, Argentina, B7600FZN | |
| GSK Investigational Site | |
| Ramos Mejia, Buenos Aires, Argentina, B1704ETD | |
| GSK Investigational Site | |
| San Justo, Buenos Aires, Argentina, B1754FPI | |
| GSK Investigational Site | |
| San Nicolas, Buenos Aires, Argentina, B2900DMH | |
| GSK Investigational Site | |
| Cordoba, Córdova, Argentina, X5000AAW | |
| GSK Investigational Site | |
| Cordoba, Córdova, Argentina, X5000EPU | |
| GSK Investigational Site | |
| Rosario, Santa Fe, Argentina, S2000CVD | |
| GSK Investigational Site | |
| Rosario, Santa Fe, Argentina, 2002 | |
| GSK Investigational Site | |
| Rosario, Santa Fe, Argentina, S2002OUR | |
| GSK Investigational Site | |
| Rosario, Santa Fe, Argentina, S2000ODA | |
| GSK Investigational Site | |
| Tucuman, Tucumán., Argentina, T4000ICL | |
| GSK Investigational Site | |
| Buenos Aires, Argentina, 1425 | |
| GSK Investigational Site | |
| Cipolletti, Argentina, R8324CVM | |
| GSK Investigational Site | |
| Corrientes, Argentina, W3400AMZ | |
| GSK Investigational Site | |
| Haedo, Buenos Aires, Argentina, B1706AJU | |
| GSK Investigational Site | |
| San Miguel de Tucuman, Argentina, T4000IFL | |
| GSK Investigational Site | |
| Santa fe, Argentina, 3000 | |
| GSK Investigational Site | |
| Sante Fe, Argentina, S3000GCI | |
| GSK Investigational Site | |
| Sante Fe, Argentina, S3000FSO | |
| GSK Investigational Site | |
| Zárate, Argentina, B2800DGH | |
| Australia, New South Wales | |
| GSK Investigational Site | |
| Camperdown, New South Wales, Australia, 2050 | |
| GSK Investigational Site | |
| Gosford, New South Wales, Australia, 2250 | |
| Australia, Queensland | |
| GSK Investigational Site | |
| Auchenflower, Queensland, Australia, 4066 | |
| GSK Investigational Site | |
| Herston, Queensland, Australia, 4029 | |
| GSK Investigational Site | |
| Milton, Queensland, Australia, 4064 | |
| Australia, South Australia | |
| GSK Investigational Site | |
| Adelaide, South Australia, Australia, 5000 | |
| GSK Investigational Site | |
| Elizabeth Vale, South Australia, Australia, 5112 | |
| Australia, Tasmania | |
| GSK Investigational Site | |
| Hobart, Tasmania, Australia, 7000 | |
| Australia, Victoria | |
| GSK Investigational Site | |
| Box Hill, Victoria, Australia, 3128 | |
| GSK Investigational Site | |
| Nedlands, Victoria, Australia, 6009 | |
| Australia, Western Australia | |
| GSK Investigational Site | |
| Fremantle, Western Australia, Australia, 6160 | |
| Australia | |
| GSK Investigational Site | |
| Ashford, Australia, 5035 | |
| GSK Investigational Site | |
| Garran, ACT, Australia, 2606 | |
| Belgium | |
| GSK Investigational Site | |
| Aalst, Belgium, 9300 | |
| GSK Investigational Site | |
| Bonheiden, Belgium, 2820 | |
| GSK Investigational Site | |
| Brussels, Belgium, 1090 | |
| GSK Investigational Site | |
| Brussels, Belgium, 1000 | |
| GSK Investigational Site | |
| Bruxelles, Belgium, 1200 | |
| GSK Investigational Site | |
| Edegem, Belgium, 2650 | |
| GSK Investigational Site | |
| La Louvière, Belgium, 7100 | |
| GSK Investigational Site | |
| Leuven, Belgium, 3000 | |
| GSK Investigational Site | |
| Liège, Belgium, 4000 | |
| GSK Investigational Site | |
| Roeselaere, Belgium, 8800 | |
| Brazil | |
| GSK Investigational Site | |
| Salvador, Bahía, Brazil, 41810010 | |
| GSK Investigational Site | |
| Fortaleza, Ceará, Brazil, 60864-190 | |
| GSK Investigational Site | |
| Goiânia - GO, Goiás, Brazil, 74605-050 | |
| GSK Investigational Site | |
| Belo Horizonte, Minas Gerais, Brazil, 30130-110 | |
| GSK Investigational Site | |
| Belo Horizonte, Minas Gerais, Brazil, 30150-221. | |
| GSK Investigational Site | |
| Campina Grande do Sul, Paraná, Brazil, 83430000 | |
| GSK Investigational Site | |
| Curitiba, Paraná, Brazil, 80730-150 | |
| GSK Investigational Site | |
| Pelotas, Rio Grande Do Sul, Brazil, 96015-290 | |
| GSK Investigational Site | |
| Porto Alegre, Rio Grande Do Sul, Brazil, 90035-903 | |
| GSK Investigational Site | |
| Porto Alegre, Rio Grande Do Sul, Brazil, 90880-480 | |
| GSK Investigational Site | |
| Porto Alegre, Rio Grande Do Sul, Brazil, 90620001 | |
| GSK Investigational Site | |
| Porto Alegre, Rio Grande Do Sul, Brazil, 90610000 | |
| GSK Investigational Site | |
| Porto Alegre, Rio Grande Do Sul, Brazil, 90020-090 | |
| GSK Investigational Site | |
| Porto Alegre, Rio Grande Do Sul, Brazil, 91350-200 | |
| GSK Investigational Site | |
| Natal, Rio Grande Du Norte, Brazil, 59020-100 | |
| GSK Investigational Site | |
| Marília, São Paulo, Brazil, 17515-000 | |
| GSK Investigational Site | |
| Sao Jose do Rio Preto, São Paulo, Brazil, 15090-000 | |
| GSK Investigational Site | |
| Sao Paulo, São Paulo, Brazil, 04024-900 | |
| GSK Investigational Site | |
| São José do Rio Preto, São Paulo, Brazil, 15015210 | |
| GSK Investigational Site | |
| Votuporanga, São Paulo, Brazil, 15500-003 | |
| GSK Investigational Site | |
| Bahia, Brazil, 40050-410 | |
| GSK Investigational Site | |
| Brasília, Brazil, 70658-700 | |
| GSK Investigational Site | |
| Campinas, Brazil, 13060-803 | |
| GSK Investigational Site | |
| Campo Grande, Brazil, 79080-090 | |
| GSK Investigational Site | |
| Rio de Janeiro, Brazil, 21041-030 | |
| GSK Investigational Site | |
| Rio De Janeiro, Brazil, RJ 22240-000 | |
| GSK Investigational Site | |
| São Paulo, Brazil, 05508-900 | |
| GSK Investigational Site | |
| São Paulo, Brazil, 05403000 | |
| GSK Investigational Site | |
| São Paulo, Brazil, 04012-180 | |
| GSK Investigational Site | |
| São Paulo - SP, Brazil, 01323-900 | |
| GSK Investigational Site | |
| Uberlandia, Brazil, 38400-902 | |
| Bulgaria | |
| GSK Investigational Site | |
| Dimitrovgrad, Bulgaria, 6400 | |
| GSK Investigational Site | |
| Haskovo, Bulgaria, 6300 | |
| GSK Investigational Site | |
| Pleven, Bulgaria, 5800 | |
| GSK Investigational Site | |
| Plovdiv, Bulgaria, 4002 | |
| GSK Investigational Site | |
| Plovdiv, Bulgaria, 4003 | |
| GSK Investigational Site | |
| Sofia, Bulgaria, 1000 | |
| GSK Investigational Site | |
| Sofia, Bulgaria, 1202 | |
| GSK Investigational Site | |
| Sofia, Bulgaria, 1527 | |
| GSK Investigational Site | |
| Sofia, Bulgaria, 1709 | |
| GSK Investigational Site | |
| Sofia, Bulgaria, 1407 | |
| GSK Investigational Site | |
| Sofia, Bulgaria, 1606 | |
| GSK Investigational Site | |
| Veliko Tarnovo, Bulgaria, 5000 | |
| Canada, Alberta | |
| GSK Investigational Site | |
| Edmonton, Alberta, Canada, T6G 2B7 | |
| Canada, British Columbia | |
| GSK Investigational Site | |
| Campbell River, British Columbia, Canada, V9W 5Y4 | |
| GSK Investigational Site | |
| New Westminister, British Columbia, Canada, V3L 3W4 | |
| GSK Investigational Site | |
| Surrey, British Columbia, Canada, V3V 1Z2 | |
| GSK Investigational Site | |
| Vancouver, British Columbia, Canada, V5Z 1M9 | |
| GSK Investigational Site | |
| Victoria, British Columbia, Canada, V8R 4R2 | |
| Canada, Newfoundland and Labrador | |
| GSK Investigational Site | |
| St. John's, Newfoundland and Labrador, Canada, A1B 3V6 | |
| Canada, Nova Scotia | |
| GSK Investigational Site | |
| Truro, Nova Scotia, Canada, B2N 1L2 | |
| Canada, Ontario | |
| GSK Investigational Site | |
| Ajax, Ontario, Canada, L1S 7K8 | |
| GSK Investigational Site | |
| Brampton, Ontario, Canada, L6Z 4N5 | |
| GSK Investigational Site | |
| Cambridge, Ontario, Canada, N1R 7R1 | |
| GSK Investigational Site | |
| Cambridge, Ontario, Canada, N1R 6V6 | |
| GSK Investigational Site | |
| Hamilton, Ontario, Canada, L8L 2X2 | |
| GSK Investigational Site | |
| Kelowna, Ontario, Canada, V1Y 1E4 | |
| GSK Investigational Site | |
| Mississauga, Ontario, Canada, L5B 2P7 | |
| GSK Investigational Site | |
| Newmarket, Ontario, Canada, L3Y 8C3 | |
| GSK Investigational Site | |
| Oshawa, Ontario, Canada, L1J 2J9 | |
| GSK Investigational Site | |
| Oshawa, Ontario, Canada, L1J 2K1 | |
| GSK Investigational Site | |
| Ottawa, Ontario, Canada, K1Y 4W7 | |
| GSK Investigational Site | |
| Sarnia, Ontario, Canada, N7T 4X3 | |
| GSK Investigational Site | |
| Sudbury, Ontario, Canada, P3C 5K7 | |
| GSK Investigational Site | |
| Sudbury, Ontario, Canada, P3E 3B8 | |
| GSK Investigational Site | |
| Thunder Bay, Ontario, Canada, P7B 7C7 | |
| GSK Investigational Site | |
| Toronto, Ontario, Canada, M4C 3E7 | |
| GSK Investigational Site | |
| Toronto, Ontario, Canada, M5C 2T2 | |
| Canada, Quebec | |
| GSK Investigational Site | |
| Greenfield Park, Quebec, Canada, JAV 2GB | |
| GSK Investigational Site | |
| Longueuil, Quebec, Canada, J4M 2X1 | |
| GSK Investigational Site | |
| Montreal, Quebec, Canada, H3G 1A4 | |
| GSK Investigational Site | |
| Montreal, Quebec, Canada, H1T 3Y7 | |
| GSK Investigational Site | |
| Sherbrooke, Quebec, Canada, J1H 5N4 | |
| GSK Investigational Site | |
| Thetford Mines, Quebec, Canada, G6G 2V4 | |
| Chile | |
| GSK Investigational Site | |
| Temuco, Región De La Araucania, Chile | |
| GSK Investigational Site | |
| Concepción, Región Del Biobio, Chile, 56-41 | |
| GSK Investigational Site | |
| Talcahuano, Región Del Biobio, Chile, 427 0918 | |
| GSK Investigational Site | |
| Santiago, Región Metro De Santiago, Chile, 7650018 | |
| GSK Investigational Site | |
| Santiago, Región Metro De Santiago, Chile, 8330024 | |
| GSK Investigational Site | |
| Santiago, Región Metro De Santiago, Chile, 750 0922 | |
| GSK Investigational Site | |
| Viña del Mar, Valparaíso, Chile | |
| GSK Investigational Site | |
| Santiago, Chile, 8900085 | |
| GSK Investigational Site | |
| Santiago, Chile, 8207257 | |
| GSK Investigational Site | |
| Temuco, Chile | |
| China, Gansu | |
| GSK Investigational Site | |
| Lanzhou, Gansu, China, 730030 | |
| China, Guangdong | |
| GSK Investigational Site | |
| Guangzhou, Guangdong, China, 510120 | |
| GSK Investigational Site | |
| Guangzhou, Guangdong, China, 510080 | |
| China, Guangxi | |
| GSK Investigational Site | |
| Nanning, Guangxi, China, 530021 | |
| China, Hainan | |
| GSK Investigational Site | |
| Haikou, Hainan, China, 570102 | |
| China, Hebei | |
| GSK Investigational Site | |
| Shijiazhuang, Hebei, China, 050000 | |
| China, Jiangsu | |
| GSK Investigational Site | |
| Nanjing, Jiangsu, China, 210029 | |
| China, Liaoning | |
| GSK Investigational Site | |
| Dalian, Liaoning, China, 116027 | |
| GSK Investigational Site | |
| Shenyang, Liaoning, China, 110004 | |
| GSK Investigational Site | |
| Shenyang, Liaoning, China, 110016 | |
| China, Shaanxi | |
| GSK Investigational Site | |
| Xian, Shaanxi, China, 710061 | |
| China, Shandong | |
| GSK Investigational Site | |
| Jinan, Shandong, China, 250033 | |
| China, Sichuan | |
| GSK Investigational Site | |
| Chengdu, Sichuan, China, 610041 | |
| China, Zhejiang | |
| GSK Investigational Site | |
| Hangzhou, Zhejiang, China, 310009 | |
| China | |
| GSK Investigational Site | |
| Beijing, China, 100037 | |
| GSK Investigational Site | |
| Beijing, China, 100853 | |
| GSK Investigational Site | |
| Beijing, China, 100020 | |
| GSK Investigational Site | |
| Beijing, China, 100050 | |
| GSK Investigational Site | |
| Beijing, China, 100029 | |
| GSK Investigational Site | |
| Beijing, China, 100730 | |
| GSK Investigational Site | |
| Hangzhou, China, 310016 | |
| GSK Investigational Site | |
| Jinan, China, 250012 | |
| GSK Investigational Site | |
| Shanghai, China, 200065 | |
| GSK Investigational Site | |
| Shanghai, China, 200003 | |
| GSK Investigational Site | |
| Shanghai, China, 200040 | |
| GSK Investigational Site | |
| Suzhou, China, 215004 | |
| Colombia | |
| GSK Investigational Site | |
| Armenia, Colombia | |
| GSK Investigational Site | |
| Barranquilla, Colombia | |
| GSK Investigational Site | |
| Bogota, Colombia | |
| GSK Investigational Site | |
| Bogota, Colombia, 38007 | |
| GSK Investigational Site | |
| Bogota, Colombia, 5600520 | |
| GSK Investigational Site | |
| Bogotá, Colombia | |
| GSK Investigational Site | |
| Bucaramanga, Colombia | |
| GSK Investigational Site | |
| Cartagena, Colombia | |
| GSK Investigational Site | |
| Manizales, Colombia | |
| GSK Investigational Site | |
| Medellin, Colombia | |
| GSK Investigational Site | |
| Medellín, Colombia | |
| Czech Republic | |
| GSK Investigational Site | |
| Brno, Czech Republic, 656 91 | |
| GSK Investigational Site | |
| Brno, Czech Republic, 625 00 | |
| GSK Investigational Site | |
| Caslav, Czech Republic, 286 01 | |
| GSK Investigational Site | |
| Jihlava, Czech Republic, 586 33 | |
| GSK Investigational Site | |
| Kromeriz, Czech Republic, 767 55 | |
| GSK Investigational Site | |
| Milevsko, Czech Republic, 399 01 | |
| GSK Investigational Site | |
| Olomouc, Czech Republic, 775 20 | |
| GSK Investigational Site | |
| Plzen - Bory, Czech Republic, 305 99 | |
| GSK Investigational Site | |
| Praha 10, Czech Republic, 100 34 | |
| GSK Investigational Site | |
| Praha 2, Czech Republic, 128 08 | |
| GSK Investigational Site | |
| Slany, Czech Republic | |
| GSK Investigational Site | |
| Svitavy, Czech Republic, 568 25 | |
| GSK Investigational Site | |
| Usti nad Orlici, Czech Republic, 562 18 | |
| GSK Investigational Site | |
| Zlin, Czech Republic, 762 75 | |
| Denmark | |
| GSK Investigational Site | |
| Aalborg, Denmark, DK-9000 | |
| GSK Investigational Site | |
| Aarhus, Denmark, DK-8000 | |
| GSK Investigational Site | |
| Esbjerg, Denmark, 6700 | |
| GSK Investigational Site | |
| Frederikssund, Denmark, DK-3600 | |
| GSK Investigational Site | |
| Glostrup, Denmark, DK-2600 | |
| GSK Investigational Site | |
| Hellerup, Denmark, 2900 | |
| GSK Investigational Site | |
| Herlev, Denmark, DK-2730 | |
| GSK Investigational Site | |
| Holbæk, Denmark, DK-4300 | |
| GSK Investigational Site | |
| Hvidovre, Denmark, DK-2650 | |
| GSK Investigational Site | |
| Koebenhavn N, Denmark, 2100 | |
| GSK Investigational Site | |
| Kolding, Denmark, DK-6000 | |
| GSK Investigational Site | |
| København NV, Denmark, DK-2400 | |
| GSK Investigational Site | |
| København S, Denmark, DK-2300 | |
| GSK Investigational Site | |
| Køge, Denmark, DK-4600 | |
| GSK Investigational Site | |
| Næstved, Denmark, 4700 | |
| GSK Investigational Site | |
| Odense C, Denmark, DK-5000 | |
| GSK Investigational Site | |
| Roskilde, Denmark, 4000 | |
| GSK Investigational Site | |
| Silkeborg, Denmark, DK-8600 | |
| GSK Investigational Site | |
| Svendborg, Denmark, 5700 | |
| France | |
| GSK Investigational Site | |
| Pau, Aquitaine, France, 64046 | |
| GSK Investigational Site | |
| Langres, Champagne-Ardenne, France, 52206 | |
| GSK Investigational Site | |
| Dunkerque, Nord-Pas-de-Calais, France, 59240 | |
| GSK Investigational Site | |
| Avignon, France, 84000 | |
| GSK Investigational Site | |
| Besançon Cedex, France, 25030 | |
| GSK Investigational Site | |
| Bron, France, 69677 | |
| GSK Investigational Site | |
| Créteil, France, 94010 | |
| GSK Investigational Site | |
| Dijon Cedex, France, 21079 | |
| GSK Investigational Site | |
| Lagny sur Marne, France, 77405 | |
| GSK Investigational Site | |
| Le Plessis Robinson, France, 92350 | |
| GSK Investigational Site | |
| Lille, France, 59000 | |
| GSK Investigational Site | |
| Marseille Cedex 08, France, 13285 | |
| GSK Investigational Site | |
| Montfermeil, France, 93370 | |
| GSK Investigational Site | |
| Paris, France, 75651 | |
| GSK Investigational Site | |
| Paris Cedex 18, France, 75877 | |
| GSK Investigational Site | |
| Poitiers, France, 86021 | |
| GSK Investigational Site | |
| Quincy sous Sénart, France, 91480 | |
| GSK Investigational Site | |
| Rennes, France, 35033 | |
| GSK Investigational Site | |
| Strasbourg Cedex, France, 67091 | |
| GSK Investigational Site | |
| Toulouse, France, 31500 | |
| GSK Investigational Site | |
| Tourcoing, France, 59200 | |
| GSK Investigational Site | |
| Valenciennes, France, 59300 | |
| Germany | |
| GSK Investigational Site | |
| Bad Krozingen, Baden-Wuerttemberg, Germany, 79189 | |
| GSK Investigational Site | |
| Freiburg, Baden-Wuerttemberg, Germany, 79106 | |
| GSK Investigational Site | |
| Heidelberg, Baden-Wuerttemberg, Germany, 69120 | |
| GSK Investigational Site | |
| Stuttgart, Baden-Wuerttemberg, Germany, 70376 | |
| GSK Investigational Site | |
| Ulm, Baden-Wuerttemberg, Germany, 89081 | |
| GSK Investigational Site | |
| Muenchen, Bayern, Germany, 80336 | |
| GSK Investigational Site | |
| Muenchen, Bayern, Germany, 81737 | |
| GSK Investigational Site | |
| Bad Nauheim, Hessen, Germany, 61231 | |
| GSK Investigational Site | |
| Darmstadt, Hessen, Germany, 64283 | |
| GSK Investigational Site | |
| Frankfurt, Hessen, Germany, 65929 | |
| GSK Investigational Site | |
| Frankfurt, Hessen, Germany, 60590 | |
| GSK Investigational Site | |
| Langen, Hessen, Germany, 63225 | |
| GSK Investigational Site | |
| Limburg, Hessen, Germany, 65549 | |
| GSK Investigational Site | |
| Bad Rothenfelde, Niedersachsen, Germany, 49214 | |
| GSK Investigational Site | |
| Hannover, Niedersachsen, Germany, 30625 | |
| GSK Investigational Site | |
| Oldenburg, Niedersachsen, Germany, 26133 | |
| GSK Investigational Site | |
| Bielefeld, Nordrhein-Westfalen, Germany, 33604 | |
| GSK Investigational Site | |
| Eschweiler, Nordrhein-Westfalen, Germany, 52249 | |
| GSK Investigational Site | |
| Essen, Nordrhein-Westfalen, Germany, 45122 | |
| GSK Investigational Site | |
| Essen, Nordrhein-Westfalen, Germany, 45359 | |
| GSK Investigational Site | |
| Neuss, Nordrhein-Westfalen, Germany, 41464 | |
| GSK Investigational Site | |
| Wuppertal, Nordrhein-Westfalen, Germany, 42117 | |
| GSK Investigational Site | |
| Ludwigshafen, Rheinland-Pfalz, Germany, 67063 | |
| GSK Investigational Site | |
| Homburg, Saarland, Germany, 66421 | |
| GSK Investigational Site | |
| Halle, Sachsen-Anhalt, Germany, 06120 | |
| GSK Investigational Site | |
| Kiel, Schleswig-Holstein, Germany, 24105 | |
| GSK Investigational Site | |
| Luebeck, Schleswig-Holstein, Germany, 23538 | |
| GSK Investigational Site | |
| Altenburg, Thueringen, Germany, 04600 | |
| GSK Investigational Site | |
| Berlin, Germany, 13353 | |
| GSK Investigational Site | |
| Berlin, Germany, 12559 | |
| GSK Investigational Site | |
| Bremen, Germany, 28277 | |
| GSK Investigational Site | |
| Hamburg, Germany, 20246 | |
| Hungary | |
| GSK Investigational Site | |
| Budapest, Hungary, 1134 | |
| GSK Investigational Site | |
| Budapest, Hungary, 1125 | |
| GSK Investigational Site | |
| Budapest, Hungary, 1032 | |
| GSK Investigational Site | |
| Budapest, Hungary, 1122 | |
| GSK Investigational Site | |
| Budapest, Hungary, 1145 | |
| GSK Investigational Site | |
| Budapest, Hungary, 1096 | |
| GSK Investigational Site | |
| Budapest, Hungary, 1106 | |
| GSK Investigational Site | |
| Cegléd, Hungary, 2700 | |
| GSK Investigational Site | |
| Eger, Hungary, 3300 | |
| GSK Investigational Site | |
| Gyula, Hungary, 5700 | |
| GSK Investigational Site | |
| Hódmezővásárhely, Hungary, 6800 | |
| GSK Investigational Site | |
| Kistarcsa, Hungary, 2143 | |
| GSK Investigational Site | |
| Miskolc, Hungary, 3526 | |
| GSK Investigational Site | |
| Szolnok, Hungary, 5004 | |
| GSK Investigational Site | |
| Szombathely, Hungary, 9700 | |
| GSK Investigational Site | |
| Székesfehérvár, Hungary, 8000 | |
| GSK Investigational Site | |
| Zalaegerszeg, Hungary, 8900 | |
| India | |
| GSK Investigational Site | |
| Ahmedabad, India, 380052 | |
| GSK Investigational Site | |
| Ahmedabad, India, 380060 | |
| GSK Investigational Site | |
| Amritsar, India, 143004 | |
| GSK Investigational Site | |
| Chennai, India, 600081 | |
| GSK Investigational Site | |
| Chennai, India, 600037 | |
| GSK Investigational Site | |
| Faridabad, India, 121001 | |
| GSK Investigational Site | |
| Gandhinagar, India, 382428 | |
| GSK Investigational Site | |
| Gurgaon, India, 122001 | |
| GSK Investigational Site | |
| Hyderabad, India, 500020 | |
| GSK Investigational Site | |
| Hyderabad, India, 500082 | |
| GSK Investigational Site | |
| Hyderabad, India, 500033 | |
| GSK Investigational Site | |
| Hyderabad, India, 500001 | |
| GSK Investigational Site | |
| Hyderabad, India, 500063 | |
| GSK Investigational Site | |
| Jaipur, India, 302017 | |
| GSK Investigational Site | |
| Lucknow, India, 226014 | |
| GSK Investigational Site | |
| Mohali, India, 160062 | |
| GSK Investigational Site | |
| New Delhi, India, 110025 | |
| GSK Investigational Site | |
| New Delhi, India, 110070 | |
| GSK Investigational Site | |
| New Delhi, India, 110060 | |
| GSK Investigational Site | |
| Noida, India, 201301 | |
| GSK Investigational Site | |
| Patiala, India, 147001 | |
| GSK Investigational Site | |
| Pune, India, 411004 | |
| GSK Investigational Site | |
| Pune,, India, 411001 | |
| GSK Investigational Site | |
| Secunderabad,, India, 500003 | |
| GSK Investigational Site | |
| Vadodara, India, 390015 | |
| GSK Investigational Site | |
| Visakhapatnam, India, 530002 | |
| Israel | |
| GSK Investigational Site | |
| Ashkelon, Israel, 78278 | |
| GSK Investigational Site | |
| Haddera, Israel, 38100 | |
| GSK Investigational Site | |
| Haifa, Israel, 34362 | |
| GSK Investigational Site | |
| Haifa, Israel, 31096 | |
| GSK Investigational Site | |
| Haifa, Israel, 31048 | |
| GSK Investigational Site | |
| Holon, Israel, 58100 | |
| GSK Investigational Site | |
| Jerusalem, Israel, 91120 | |
| GSK Investigational Site | |
| Jerusalem, Israel, 91031 | |
| GSK Investigational Site | |
| Jerusalem, Israel, 91240 | |
| GSK Investigational Site | |
| Jerusalem, Israel, 91004 | |
| GSK Investigational Site | |
| Kfar Saba, Israel, 44281 | |
| GSK Investigational Site | |
| Nahariya, Israel, 22100 | |
| GSK Investigational Site | |
| Poriya, Israel, 15208 | |
| GSK Investigational Site | |
| Raanana, Israel, 43000 | |
| GSK Investigational Site | |
| Ramat-Gan, Israel, 52621 | |
| GSK Investigational Site | |
| Rehovot, Israel, 76100 | |
| GSK Investigational Site | |
| Safed, Israel, 13110 | |
| GSK Investigational Site | |
| Tel Aviv, Israel, 64239 | |
| Italy | |
| GSK Investigational Site | |
| Napoli, Campania, Italy, 80131 | |
| GSK Investigational Site | |
| Bologna, Emilia-Romagna, Italy, 40138 | |
| GSK Investigational Site | |
| Carpi, Emilia-Romagna, Italy, 41012 | |
| GSK Investigational Site | |
| Ferrara, Emilia-Romagna, Italy, 44100 | |
| GSK Investigational Site | |
| Parma, Emilia-Romagna, Italy, 43100 | |
| GSK Investigational Site | |
| Palmanova, Friuli-Venezia-Giulia, Italy, 33057 | |
| GSK Investigational Site | |
| San Daniele del Friuli, Friuli-Venezia-Giulia, Italy, 33038 | |
| GSK Investigational Site | |
| Udine, Friuli-Venezia-Giulia, Italy, 33100 | |
| GSK Investigational Site | |
| Roma, Lazio, Italy, 00168 | |
| GSK Investigational Site | |
| Roma, Lazio, Italy, 00189 | |
| GSK Investigational Site | |
| Roma, Lazio, Italy, 00135 | |
| GSK Investigational Site | |
| Bergamo, Lombardia, Italy, 24128 | |
| GSK Investigational Site | |
| Milano, Lombardia, Italy, 20162 | |
| GSK Investigational Site | |
| Ascoli Piceno, Marche, Italy, 63100 | |
| GSK Investigational Site | |
| Novara, Piemonte, Italy, 28100 | |
| GSK Investigational Site | |
| Sassari, Sardegna, Italy, 07100 | |
| GSK Investigational Site | |
| Pisa, Toscana, Italy, 56126 | |
| GSK Investigational Site | |
| Treviso, Veneto, Italy, 31100 | |
| GSK Investigational Site | |
| Legnano, Italy, 20025 | |
| GSK Investigational Site | |
| Sassuolo, Italy, 41049 | |
| Japan | |
| GSK Investigational Site | |
| Chiba, Japan, 270-2251 | |
| GSK Investigational Site | |
| Fukuoka, Japan, 816-0864 | |
| GSK Investigational Site | |
| Fukuoka, Japan, 811-0213 | |
| GSK Investigational Site | |
| Fukuoka, Japan, 807-0051 | |
| GSK Investigational Site | |
| Hokkaido, Japan, 063-0005 | |
| GSK Investigational Site | |
| Hokkaido, Japan, 006-8555 | |
| GSK Investigational Site | |
| Hokkaido, Japan, 065-0033 | |
| GSK Investigational Site | |
| Hyogo, Japan, 650-0047 | |
| GSK Investigational Site | |
| Kanagawa, Japan, 247-8533 | |
| GSK Investigational Site | |
| Kanagawa, Japan, 243-8551 | |
| GSK Investigational Site | |
| Kanagawa, Japan, 232-0024 | |
| GSK Investigational Site | |
| Kyoto, Japan, 606-8507 | |
| GSK Investigational Site | |
| Nagasaki, Japan, 856-8562 | |
| GSK Investigational Site | |
| Oita, Japan, 870-0263 | |
| GSK Investigational Site | |
| Okayama, Japan, 700-8558 | |
| GSK Investigational Site | |
| Osaka, Japan, 574-0074 | |
| GSK Investigational Site | |
| Osaka, Japan, 580-0032 | |
| GSK Investigational Site | |
| Osaka, Japan, 565-8565 | |
| GSK Investigational Site | |
| Saga, Japan, 843-0393 | |
| GSK Investigational Site | |
| Shizuoka, Japan, 410-2295 | |
| GSK Investigational Site | |
| Tokyo, Japan, 113-8431 | |
| GSK Investigational Site | |
| Tokyo, Japan, 196-0003 | |
| GSK Investigational Site | |
| Tokyo, Japan, 101-8643 | |
| GSK Investigational Site | |
| Tokyo, Japan, 160-8582 | |
| Korea, Republic of | |
| GSK Investigational Site | |
| Dae-Gu, Korea, Republic of, 700-721 | |
| GSK Investigational Site | |
| Daejeon, Korea, Republic of, 301721 | |
| GSK Investigational Site | |
| Gangnam-gu, Seoul, Korea, Republic of, 135-710 | |
| GSK Investigational Site | |
| Gwangju, Korea, Republic of, 501-757 | |
| GSK Investigational Site | |
| Kangwon-do, Korea, Republic of, 220-701 | |
| GSK Investigational Site | |
| Pusan, Korea, Republic of, 602-739 | |
| GSK Investigational Site | |
| Seoul, Korea, Republic of, 137-701 | |
| GSK Investigational Site | |
| Seoul, Korea, Republic of, 110-744 | |
| GSK Investigational Site | |
| Seoul, Korea, Republic of, 138-736 | |
| GSK Investigational Site | |
| Seoul, Korea, Republic of, 120-752 | |
| Netherlands | |
| GSK Investigational Site | |
| 's-Hertogenbosch, Netherlands, 5223 GZ | |
| GSK Investigational Site | |
| Amersfoort, Netherlands, 3818 ES | |
| GSK Investigational Site | |
| Amsterdam, Netherlands, 1061 AE | |
| GSK Investigational Site | |
| Amsterdam, Netherlands, 1105 AZ | |
| GSK Investigational Site | |
| Amsterdam, Netherlands, 1091 AC | |
| GSK Investigational Site | |
| Blaricum, Netherlands, 1261 AN | |
| GSK Investigational Site | |
| Den Haag, Netherlands, 2597 AX | |
| GSK Investigational Site | |
| Deventer, Netherlands, 7416 SE | |
| GSK Investigational Site | |
| Dirksland, Netherlands, 3247 BW | |
| GSK Investigational Site | |
| Doetinchem, Netherlands, 7009 BL | |
| GSK Investigational Site | |
| Drachten, Netherlands, 9202 NN | |
| GSK Investigational Site | |
| Gorinchem, Netherlands, 4204 AA | |
| GSK Investigational Site | |
| Gouda, Netherlands, 2803 HH | |
| GSK Investigational Site | |
| Groningen, Netherlands, 9728 NT | |
| GSK Investigational Site | |
| Hardenberg, Netherlands, 7772 SE | |
| GSK Investigational Site | |
| Harderwijk, Netherlands, 3844 DG | |
| GSK Investigational Site | |
| Heerenveen, Netherlands, 8441 PW | |
| GSK Investigational Site | |
| Heerlen, Netherlands, 6419 PC | |
| GSK Investigational Site | |
| Helmond, Netherlands, 5707 HA | |
| GSK Investigational Site | |
| Hilversum, Netherlands, 1213 XZ | |
| GSK Investigational Site | |
| Hoofddorp, Netherlands, 2134 TM | |
| GSK Investigational Site | |
| Hoorn, Netherlands, 1625 HV | |
| GSK Investigational Site | |
| Nijmegen, Netherlands, 6532 SZ | |
| GSK Investigational Site | |
| OSS, Netherlands, 5342 BT | |
| GSK Investigational Site | |
| Roermond, Netherlands, 6043 CV | |
| GSK Investigational Site | |
| Rotterdam, Netherlands, 3083 AN | |
| GSK Investigational Site | |
| Rotterdam, Netherlands, 3045 PM | |
| GSK Investigational Site | |
| Sittard-geleen, Netherlands, 6162 BG | |
| GSK Investigational Site | |
| Sneek, Netherlands, 8601 ZR | |
| GSK Investigational Site | |
| Tiel, Netherlands, 4002 WP | |
| GSK Investigational Site | |
| Tilburg, Netherlands, 5042AD | |
| GSK Investigational Site | |
| Veldhoven, Netherlands, 5504 DB | |
| GSK Investigational Site | |
| Venlo, Netherlands, 5912 BL | |
| GSK Investigational Site | |
| Zoetermeer, Netherlands, 2725 NA | |
| New Zealand | |
| GSK Investigational Site | |
| Auckland, New Zealand | |
| GSK Investigational Site | |
| Auckland, New Zealand, 2025 | |
| GSK Investigational Site | |
| Christchurch, New Zealand | |
| GSK Investigational Site | |
| Dunedin, New Zealand | |
| GSK Investigational Site | |
| Hamilton, New Zealand, 3204 | |
| GSK Investigational Site | |
| Lower Hutt, New Zealand, 6007 | |
| GSK Investigational Site | |
| New Plymouth, New Zealand, 4310 | |
| GSK Investigational Site | |
| Palmerston North, New Zealand | |
| GSK Investigational Site | |
| Takapuna, Auckland, New Zealand, 0622 | |
| GSK Investigational Site | |
| Tauranga, New Zealand | |
| GSK Investigational Site | |
| Whangarei, New Zealand | |
| Peru | |
| GSK Investigational Site | |
| Miraflores, Lima, Lima, Peru, Lima 18 | |
| GSK Investigational Site | |
| San Martin de Porres, Lima, Peru, Lima 31 | |
| GSK Investigational Site | |
| Callao, Peru, Callao 02 | |
| GSK Investigational Site | |
| Lima, Peru, Lima 27 | |
| GSK Investigational Site | |
| Lima, Peru, Lima 33 | |
| GSK Investigational Site | |
| Lima Cercado, Peru, LIMA 01 | |
| Philippines | |
| GSK Investigational Site | |
| Cebu City, Philippines, 6000 | |
| GSK Investigational Site | |
| Davao, Philippines, 8000 | |
| GSK Investigational Site | |
| Manila, Philippines, 1000 | |
| GSK Investigational Site | |
| Quezon City, Philippines, 1113 | |
| GSK Investigational Site | |
| Quezon City, Philippines, 1109 | |
| GSK Investigational Site | |
| Quezon City, Philippines, 1100 | |
| Poland | |
| GSK Investigational Site | |
| Bialystok, Poland, 15-276 | |
| GSK Investigational Site | |
| Bydgoszcz, Poland, 85-079 | |
| GSK Investigational Site | |
| Bytom, Poland, 41-902 | |
| GSK Investigational Site | |
| Chrzanow, Poland, 32-500 | |
| GSK Investigational Site | |
| Gdansk, Poland, 80-952 | |
| GSK Investigational Site | |
| Gdynia, Poland, 81-472 | |
| GSK Investigational Site | |
| Gdynia, Poland, 81-423 | |
| GSK Investigational Site | |
| Gdynia, Poland, 81-519 | |
| GSK Investigational Site | |
| Inowroclaw, Poland | |
| GSK Investigational Site | |
| Krakow, Poland, 31-121 | |
| GSK Investigational Site | |
| Krakow, Poland, 31-202 | |
| GSK Investigational Site | |
| Lodz, Poland, 91-347 | |
| GSK Investigational Site | |
| Lubin, Poland, 59-300 | |
| GSK Investigational Site | |
| Mielec, Poland, 39-300 | |
| GSK Investigational Site | |
| Olawa, Poland, 55-200 | |
| GSK Investigational Site | |
| Opole, Poland, 45-418 | |
| GSK Investigational Site | |
| Radom, Poland, 26-617 | |
| GSK Investigational Site | |
| Skierniewice, Poland, 96-100 | |
| GSK Investigational Site | |
| Tarnow, Poland, 33-100 | |
| GSK Investigational Site | |
| Torun, Poland, 87-100 | |
| GSK Investigational Site | |
| Tychy, Poland, 43-100 | |
| GSK Investigational Site | |
| Walbrzych, Poland, 58-309 | |
| GSK Investigational Site | |
| Warsaw, Poland, 02-507 | |
| GSK Investigational Site | |
| Warszawa, Poland, 00-685 | |
| GSK Investigational Site | |
| Warszawa, Poland, 04-073 | |
| GSK Investigational Site | |
| Warszawa, Poland, 02-637 | |
| GSK Investigational Site | |
| Wloclawek, Poland, 87-800 | |
| GSK Investigational Site | |
| Wroclaw, Poland, 50-349 | |
| GSK Investigational Site | |
| Wroclaw, Poland, 50-367 | |
| GSK Investigational Site | |
| Wroclaw, Poland, 51-124 | |
| GSK Investigational Site | |
| Zamosc, Poland, 22-400 | |
| GSK Investigational Site | |
| Zielona Gora, Poland, 65-046 | |
| Romania | |
| GSK Investigational Site | |
| Baia Mare, Romania, 430123 | |
| GSK Investigational Site | |
| Braila, Romania, 810249 | |
| GSK Investigational Site | |
| Brasov, Romania, 500326 | |
| GSK Investigational Site | |
| Bucharest, Romania, 014461 | |
| GSK Investigational Site | |
| Bucharest, Romania, 041915 | |
| GSK Investigational Site | |
| Bucharest, Romania, 011461 | |
| GSK Investigational Site | |
| Bucharest, Romania, 011794 | |
| GSK Investigational Site | |
| Bucharest, Romania, 022328 | |
| GSK Investigational Site | |
| Bucharest, Romania, 050098 | |
| GSK Investigational Site | |
| Cluj-Napoca, Romania, 400001 | |
| GSK Investigational Site | |
| Constanta, Romania, 900591 | |
| GSK Investigational Site | |
| Craiova, Romania, 200642 | |
| GSK Investigational Site | |
| Iasi, Romania, 700503 | |
| GSK Investigational Site | |
| Targu Mures, Romania, 540136 | |
| Russian Federation | |
| GSK Investigational Site | |
| Barnaul, Russian Federation, 656024 | |
| GSK Investigational Site | |
| Ekaterinburg, Russian Federation, 620039 | |
| GSK Investigational Site | |
| Ekaterinburg, Russian Federation, 620109 | |
| GSK Investigational Site | |
| Gatchina, Russian Federation, 188300 | |
| GSK Investigational Site | |
| Kemerovo, Russian Federation, 650036 | |
| GSK Investigational Site | |
| Kemerovo, Russian Federation, 650002 | |
| GSK Investigational Site | |
| Krasnoyarsk, Russian Federation, 660097 | |
| GSK Investigational Site | |
| Moscow, Russian Federation, 119991 | |
| GSK Investigational Site | |
| Moscow, Russian Federation, 111539 | |
| GSK Investigational Site | |
| Moscow, Russian Federation, 117292 | |
| GSK Investigational Site | |
| Moscow, Russian Federation, 127473 | |
| GSK Investigational Site | |
| Moscow, Russian Federation, 127018 | |
| GSK Investigational Site | |
| Moscow, Russian Federation, 121 309 | |
| GSK Investigational Site | |
| Moscow, Russian Federation, 105187 | |
| GSK Investigational Site | |
| Moscow, Russian Federation, 119620 | |
| GSK Investigational Site | |
| Moscow, Russian Federation, 121552 | |
| GSK Investigational Site | |
| Moscow, Russian Federation, 111020 | |
| GSK Investigational Site | |
| Nizhniy Novgorod, Russian Federation, 603076 | |
| GSK Investigational Site | |
| Nizhniy Novgorod, Russian Federation, 603035 | |
| GSK Investigational Site | |
| Novosibirsk, Russian Federation, 630047 | |
| GSK Investigational Site | |
| Novosibirsk, Russian Federation, 630008 | |
| GSK Investigational Site | |
| Orenburg, Russian Federation, 460040 | |
| GSK Investigational Site | |
| Samara, Russian Federation, 443070 | |
| GSK Investigational Site | |
| Saratov, Russian Federation, 410028 | |
| GSK Investigational Site | |
| Saratov, Russian Federation, 410054 | |
| GSK Investigational Site | |
| St'Petersburg, Russian Federation, 194156 | |
| GSK Investigational Site | |
| St-Petersburg, Russian Federation, 199106 | |
| GSK Investigational Site | |
| St-Petersburg, Russian Federation, 193312 | |
| GSK Investigational Site | |
| St-Petersburg, Russian Federation, 195067 | |
| GSK Investigational Site | |
| St. Petersburg, Russian Federation, 193079 | |
| GSK Investigational Site | |
| St. Petersburg, Russian Federation, 198205 | |
| GSK Investigational Site | |
| St. Petersburg, Russian Federation, 192242 | |
| GSK Investigational Site | |
| St. Petersburg, Russian Federation, 196247 | |
| GSK Investigational Site | |
| St. Petersburg, Russian Federation, 190000 | |
| GSK Investigational Site | |
| St. Petersburg, Russian Federation, 198013 | |
| GSK Investigational Site | |
| St. Petersburg, Russian Federation, 196601 | |
| GSK Investigational Site | |
| Tomsk, Russian Federation, 643012 | |
| GSK Investigational Site | |
| Tyumen, Russian Federation, 625026 | |
| GSK Investigational Site | |
| Tyumen, Russian Federation, 625023 | |
| GSK Investigational Site | |
| Yaroslavl, Russian Federation, 150003 | |
| Slovakia | |
| GSK Investigational Site | |
| Bratislava, Slovakia, 833 05 | |
| GSK Investigational Site | |
| Bratislava, Slovakia, 813 69 | |
| GSK Investigational Site | |
| Bratislava, Slovakia, 833 48 | |
| GSK Investigational Site | |
| Kosice, Slovakia, 040 22 | |
| GSK Investigational Site | |
| Nitra, Slovakia, 949 01 | |
| GSK Investigational Site | |
| Nitra, Slovakia, 950 01 | |
| GSK Investigational Site | |
| Nove Zamky, Slovakia, 940 52 | |
| South Africa | |
| GSK Investigational Site | |
| Bloemfontein, Free State, South Africa, 9301 | |
| GSK Investigational Site | |
| Alberton, Gauteng, South Africa, 1449 | |
| GSK Investigational Site | |
| Johannesburg, Gauteng, South Africa, 2000 | |
| GSK Investigational Site | |
| Pretoria, Gauteng, South Africa, 0001 | |
| GSK Investigational Site | |
| Pretoria, Gauteng, South Africa, 0132 | |
| GSK Investigational Site | |
| Durban, KwaZulu- Natal, South Africa, 4052 | |
| GSK Investigational Site | |
| Durban, KwaZulu- Natal, South Africa, 4001 | |
| GSK Investigational Site | |
| Cape Town, Western Province, South Africa, 7530 | |
| GSK Investigational Site | |
| Cape Town, Western Province, South Africa, 7500 | |
| GSK Investigational Site | |
| Panorama, Western Province, South Africa, 7500 | |
| GSK Investigational Site | |
| Goodwood, South Africa, 7460 | |
| GSK Investigational Site | |
| Kempton Park, South Africa, 1619 | |
| GSK Investigational Site | |
| Paarl, South Africa, 7646 | |
| GSK Investigational Site | |
| Parktown West, South Africa, 2193 | |
| GSK Investigational Site | |
| Parow, South Africa, 7505 | |
| GSK Investigational Site | |
| Pretoria, South Africa, 0002 | |
| GSK Investigational Site | |
| Pretoria, South Africa, 0041 | |
| GSK Investigational Site | |
| Somerset West, South Africa, 7130 | |
| GSK Investigational Site | |
| Worcester, South Africa, 6850 | |
| Spain | |
| GSK Investigational Site | |
| Alicante, Spain, 03010 | |
| GSK Investigational Site | |
| Barcelona, Spain, 08035 | |
| GSK Investigational Site | |
| Lerida, Spain, 25198 | |
| GSK Investigational Site | |
| León, Spain, 24071 | |
| GSK Investigational Site | |
| Madrid, Spain, 28006 | |
| GSK Investigational Site | |
| Madrid, Spain, 28046 | |
| GSK Investigational Site | |
| Malaga, Spain, 29010 | |
| GSK Investigational Site | |
| Oviedo, Spain, 33006 | |
| GSK Investigational Site | |
| San Juan/Alicante, Spain, 03550 | |
| GSK Investigational Site | |
| San Sebastián, Spain, 20014 | |
| GSK Investigational Site | |
| San Sebastián de los Reyes/Madrid, Spain | |
| GSK Investigational Site | |
| Sevilla, Spain, 41009 | |
| GSK Investigational Site | |
| Valencia, Spain, 46014 | |
| GSK Investigational Site | |
| Vigo/Pontevedra, Spain, 36200 | |
| Sweden | |
| GSK Investigational Site | |
| Göteborg, Sweden, SE-43180 | |
| GSK Investigational Site | |
| Göteborg, Sweden, SE-41685 | |
| GSK Investigational Site | |
| Göteborg, Sweden, SE-413 45 | |
| GSK Investigational Site | |
| Hässleholm, Sweden, SE-28125 | |
| GSK Investigational Site | |
| Jönköping, Sweden, SE-551 85 | |
| GSK Investigational Site | |
| Stockholm, Sweden, SE-11883 | |
| GSK Investigational Site | |
| Västerås, Sweden, SE-721 89 | |
| GSK Investigational Site | |
| Örebro, Sweden, SE-70185 | |
| GSK Investigational Site | |
| Östersund, Sweden, SE-831 83 | |
| Taiwan | |
| GSK Investigational Site | |
| Kaohsiung, Taiwan, 833 | |
| GSK Investigational Site | |
| Kaohsiung City, Taiwan, 807 | |
| GSK Investigational Site | |
| Taipei, Taiwan, 220 | |
| GSK Investigational Site | |
| Taipei, Taiwan, 111 | |
| GSK Investigational Site | |
| Taipei, Taiwan, 112 | |
| GSK Investigational Site | |
| Yung Kang City, Taiwan, 71044 | |
| Thailand | |
| GSK Investigational Site | |
| Bangkok, Thailand, 10400 | |
| GSK Investigational Site | |
| Bangkoknoi, Thailand, 10700 | |
| GSK Investigational Site | |
| Chiangmai, Thailand, 50200 | |
| GSK Investigational Site | |
| Khon Kaen, Muang, Thailand, 40002 | |
| GSK Investigational Site | |
| Nakhon Ratchasima, Thailand, 30000 | |
| GSK Investigational Site | |
| Pathumthani, Thailand, 12120 | |
| Turkey | |
| GSK Investigational Site | |
| Ankara, Turkey, 06500 | |
| GSK Investigational Site | |
| Erzurum, Turkey, 25240 | |
| GSK Investigational Site | |
| Eskisehir, Turkey, 26480 | |
| GSK Investigational Site | |
| Izmir, Turkey, 35340 | |
| GSK Investigational Site | |
| Izmir, Turkey, 35360 | |
| GSK Investigational Site | |
| Izmir, Turkey, 35100 | |
| Ukraine | |
| GSK Investigational Site | |
| Dnipropetrovsk, Ukraine, 49006 | |
| GSK Investigational Site | |
| Donetsk, Ukraine, 83114 | |
| GSK Investigational Site | |
| Kharkiv, Ukraine, 61002 | |
| GSK Investigational Site | |
| Kharkiv, Ukraine, 61018 | |
| GSK Investigational Site | |
| Kharkiv, Ukraine, 61176 | |
| GSK Investigational Site | |
| Kharkiv, Ukraine, 61039 | |
| GSK Investigational Site | |
| Kyiv, Ukraine, 02091 | |
| GSK Investigational Site | |
| Kyiv, Ukraine, 3115 | |
| GSK Investigational Site | |
| Kyiv, Ukraine, 01601 | |
| GSK Investigational Site | |
| Kyiv, Ukraine, 03049 | |
| GSK Investigational Site | |
| Kyiv, Ukraine, 03680 | |
| GSK Investigational Site | |
| Kyiv, Ukraine, 02660 | |
| GSK Investigational Site | |
| Lugansk, Ukraine, 91045 | |
| GSK Investigational Site | |
| Lutsk, Ukraine, 43024 | |
| GSK Investigational Site | |
| Mykolaiv, Ukraine, 54033 | |
| GSK Investigational Site | |
| Odesa, Ukraine, 65014 | |
| GSK Investigational Site | |
| Simferopol, Ukraine, 95026 | |
| GSK Investigational Site | |
| Vinnytsia, Ukraine, 21029 | |
| GSK Investigational Site | |
| Vinnytsia, Ukraine, 21018 | |
| GSK Investigational Site | |
| Zaporizhzhya, Ukraine, 69000 | |
| United Kingdom | |
| GSK Investigational Site | |
| Exeter, Devon, United Kingdom, EX2 5DW | |
| GSK Investigational Site | |
| Torquay, Devon, United Kingdom, TQ2 7AA | |
| GSK Investigational Site | |
| Airdrie, Lanarkshire, United Kingdom, ML6 0JS | |
| GSK Investigational Site | |
| Harrow, Middlesex, United Kingdom, HA1 3UJ | |
| GSK Investigational Site | |
| Northampton, Northamptonshire, United Kingdom, NN1 5BD | |
| GSK Investigational Site | |
| Nottingham, Nottinghamshire, United Kingdom, NG5 1PB | |
| GSK Investigational Site | |
| Chertsey, Surrey, United Kingdom, KT16 0PZ | |
| GSK Investigational Site | |
| Coventry, West Midlands, United Kingdom, CV2 2DX | |
| GSK Investigational Site | |
| Antrim, United Kingdom, BT41 2RL | |
| GSK Investigational Site | |
| Chichester, United Kingdom, PO19 6SE | |
| GSK Investigational Site | |
| East Kilbride, United Kingdom, G75 8RG | |
| GSK Investigational Site | |
| Hertfordshire, United Kingdom | |
| GSK Investigational Site | |
| Liverpool, United Kingdom, L7 8XP | |
| GSK Investigational Site | |
| Paisley, United Kingdom, PA2 9PN | |
| GSK Investigational Site | |
| Stirling, United Kingdom, FK8 2AU | |
Sponsors and Collaborators
GlaxoSmithKline
The TIMI Study Group
Investigators
| Study Director: | GSK Clinical Trials | GlaxoSmithKline |
More Information
No publications provided by GlaxoSmithKline
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | GlaxoSmithKline |
| ClinicalTrials.gov Identifier: | NCT01000727 History of Changes |
| Other Study ID Numbers: | 480848/033 |
| Study First Received: | October 22, 2009 |
| Last Updated: | October 25, 2012 |
| Health Authority: | Spain: Agencia Espanola de Medicamentos y Productos Sanitarios Slovakia: State Institute for Drug Control Estonia: State Agency of Medicines Colombia: INVIMA Chile: Institutional Review Board Brazil: Institutional Review Board Peru: Institutional Review Board Greece: National Ethics Committee United Kingdom: Medicines and Healthcare Products Regulatory Agency Italy: Comitato Etico Unico per la Provincia di Parma - Via Gramsci, 14- 43100 Parma Belgium: Federal Agency for Medicinal Products and Health Products Bulgaria: The Bulgarian Drug Agency Argentina: Ministry of Health - A.N.M.A.T Romania: Agentia Nationala a Medicamentului Ukraine: The Central Ethics Committee of Ministry of Health of Ukraine Japan: Pharmaceutical and Medical Device Agency Russia: Federal Service of Surveillance in Healthcare and Social development of Russian federation Norway: Statens Legemiddelverk Taiwan: Department of Health India: Drugs Controller General of India Thailand: Ministry of Public Health Philippines: Bureau of Food and Drugs Hungary: Országos Gyógyszerészeti Intézet South Africa: Medicines Control Council Poland: URZ.D REJESTRACJI PRODUKTÓW LECZNICZYCH, WYROBÓW MEDYCZNYCH I PRODUKTÓW BIOBÓJCZYCH,CEBK Mexico: Ministry of Health New Zealand: Medicines and Medical Devices Safety Authority Denmark: Danish Medicines Agency France: Agence Française de Sécurité Sanitaire des Produits de Santé Germany: Federal Institute for Drugs and Medical Devices Netherlands: De Centrale Commissie Mensgebonden Onderzoek Israel: Ministry of Health Czech: State Institute for Drug Control China: Food and Drug Administration South Korea: Food and Drug Administration United States: Food and Drug Administration Sweden: Läkemedelsverket Turkey: Ministry of Health Australia: Therapeutic Goods Administration Greece: National Drug Organisation |
Keywords provided by GlaxoSmithKline:
|
Atherosclerosis Heart disease Cardiovascular disease Lp-PLA2 inhibitor |
The TIMI Study Group Coronary Heart Disease (CHD) Acute Coronary Syndrome (ACS) |
Additional relevant MeSH terms:
|
Atherosclerosis Cardiovascular Diseases Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases Myocardial Infarction Acute Coronary Syndrome |
Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases Angina Pectoris Chest Pain Pain Signs and Symptoms |
ClinicalTrials.gov processed this record on May 16, 2013